The diabetes and weight loss medications Ozempic and Wegovy are now considered to be available after more than two years ...

After years of ongoing shortages due to their growing popularity, all doses of both Ozempic and Wegovy are now listed as ...

It is a sign that Novo Nordisk’s efforts to ramp up the supply of those drugs are starting to pay off, as demand continues to ...

People with Type 2 diabetes taking semaglutide appeared to have a significantly lower risk of developing Alzheimer's compared ...

Type-2 diabetes patients taking the active ingredient in the drugs, semaglutide, "had a significantly lower risk" of ...

A new study reveals that the active ingredient in drugs like Ozempic and Wegovy could lower the risk of developing ...

With the cost of GLP-1s rising for employers, so-called compounded weight-loss drugs have emerged as a more cost-conscious ...

All doses of the two drugs are now listed as available in the U.S., per an FDA database, although the company cautioned ...

Semaglutide, the scientific name for Novo’s GLP-1 diabetes drug Ozempic and obesity drug Wegovy, has been on the shortage ...

Semaglutide, the main ingredient in Ozempic and Wegovy, improves type 2 diabetes, heart disease, smoking, and alcohol ...

As weight-loss injections emerge as key players in the government’s anti-obesity strategy, Emma Loffhagen goes inside the ...